« Return to News | Technology Solutions

Datatrak Delisted from NASDAQ

Wednesday, June 10, 2009 07:30 AM

Datatrak, a Cleveland-based  eClinical company, was delisted from the stock exchange after failing to meet NASDAQ's $2.5-million minimum stockholders' equity requirement.

The company will trade its shares over the counter under the same symbol (DATA).  The delisting came as no surprise to Datatrak, which received a letter from NASDAQ last August warning the company that it was not in compliance with the stock exchange's minimum equity requirement. Datatrak had until June 1 to comply with NASDAQ's requirements.

Datatrak's struggles began more than a year ago as the company posted several quarters of losses and retained Healthcare Growth Partners as a strategic and financial advisor in an effort to increase the company's value. For the most recent quarter, Datatrak's loss was $787,000, a decrease from more than $2 million for the same period last year.

CEO Jeffrey Green stepped down in January, after 17 years, and the company has yet to replace him.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.